Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Dr. Reddy’s announced the launch of Ziprasidone Mesylate for Injection, 20 mg (base)/mL Single-dose Vials, the generic equivalent of Geodon.
read more
Pfizer and BioNTech announced the companies have agreed to a letter of intent regarding the co-development and distribution of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection.
read more
Catalent welcomed the announcement by Biohaven the FDA has approved its NURTEC™ ODT for acute migraine in adults.
read more
Emergent BioSolutions will collaborate with Novavax to support bringing into the clinic Novavax’s novel experimental vaccine candidate to protect against coronavirus disease (COVID-19).
read more
ImprimisRx has agreed to a product supply agreement with EyeCare Services Partners (ESP).
read more
The FDA finalized guidance for industry, “Competitive Generic Therapies,” which describes the process that generic drug applicants should follow to request designation of a drug as a CGT and the criteria for that designation.
read more
Clearside Biomedical announced Arctic Vision has acquired an exclusive license for the commercialization and development of XIPERE in Greater China and South Korea.
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
Wednesday, March 11, 2020
The FDA and the FTC issued warning letters to seven companies for selling fraudulent COVID-19 products.
read more
Beroni announced its development of a medical solution using nanobody technology for the novel coronavirus in collaboration with Tianjin University has advanced into cytological experiments.
read more
The FDA announced a change to the law will impact compounding of certain products beginning on March 23, 2020.
read more
Wednesday, March 04, 2020
Alopexx Oncology has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.
read more
Abpro announced the formation of a strategic partnership to advance two bispecific antibodies in key Asian markets including Greater China, Japan, and South Korea.
read more
Friday, February 28, 2020
Merck KGaA, Darmstadt, Germany and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets.
read more
Thursday, February 27, 2020
Catalent announced the FDA has approved AYVAKIT for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor.
read more